IMARC Group has recently released a report titled “Chronic Kidney Disease Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)” that presents a comprehensive assessment of the chronic kidney disease market , latest trends, and growth forecast. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market scenario, and growth trends. Furthermore, the report offers an analysis of competitors, regional markets, and recent advancements in the global market. It also sheds light on crucial segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the chronic kidney disease market.
Chronic kidney disease is a medical disorder in which progressive damage and gradual loss of renal function occur over time. Some of the common symptoms of the ailment are nausea, fatigue, weakness, muscle cramps, shortness of breath, loss of appetite, vomiting, dry and itchy skin, swelling of the feet and ankles, etc. A study of the patient’s symptoms and medical history, along with a physical and neurological evaluation, are usually required to diagnose the illness. The healthcare provider may perform several investigations, such as blood workups, imaging studies, urine tests, etc., to determine the severity of the disease.
Request a Free Sample Report : https://www.imarcgroup.com/chronic-kidney-disease-market/requestsample
The elevating cases of high blood pressure and diabetes, which can exert strain on the renal blood vessels and cause damage, are primarily augmenting the chronic kidney disease market. Additionally, the increasing incidence of renal stones, enlarged prostates, and some cancers that result in prolonged obstruction of the urinary tract are further catalyzing the market growth. Besides this, the rising utilization of effective drugs, including angiotensin-converting enzyme (ACE) inhibitors, diuretics, statins, etc., to treat the underlying symptoms is acting as another significant growth-inducing factor.
Furthermore, the escalating application of peritoneal dialysis therapy, which utilizes the lining of the abdominal cavity to eliminate unwanted fluid and waste from the body, is positively influencing the market growth. Additionally, the emerging popularity of sodium-glucose co-transporter 2 (SGLT2) inhibitors, including empagliflozin and canagliflozin, for treating this condition since they can minimize albuminuria and enhance renal outcomes, is projected to fuel the chronic kidney disease market over the forecasted period.
Report Period:
Base Year: 2022Historical Period: 2017-2022Market Forecast: 2023-2033Countries Included:
United StatesGermanyFranceUnited KingdomItalySpainJapanAnalysis Covered Across Each Country
Historical, current, and future epidemiology scenarioHistorical, current, and future performance of the chronic kidney disease marketHistorical, current, and future performance of various therapeutic categories in the marketSales of various drugs across the chronic kidney disease marketReimbursement scenario in the marketIn-market and pipeline drugsIn-Market Drugs
Drug OverviewMechanism of ActionRegulatory StatusClinical Trial ResultsDrug Uptake and Market PerformanceLate-Stage Pipeline Drugs
Drug OverviewMechanism of ActionRegulatory StatusClinical Trial ResultsRegulatory StatusAsk an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/chronic-kidney-disease-market
Key Questions Answered in this Report:
How has the chronic kidney disease market performed so far and how will it perform in the coming years?What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?What was the country-wise size of the chronic kidney disease market across the seven major markets in 2022 and what will it look like in 2033?What is the growth rate of the chronic kidney disease market across the seven major markets and what will be the expected growth over the next ten years?What are the key unmet needs in the market?Browse the Latest Research Report:
Hypertrophic Scar Market Report 2023-2033
Hepatitis C Market Report 2023-2033
Hypertrophic Cardiomyopathy Market Report 2023-2033
Hepatitis B Market Report 2023-2033
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: [email protected]
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Sign in to leave a comment.